Clinical Intelligence · DACH Market
Unlock the Power of
Precision in Pharma:
Expert Physician Profiling and Segmentation for Targeted Strategies.
EvoluMedica delivers manual, qualitative HCP intelligence for clinical trial site selection and physician profiling — precisely where automated databases fall short.
Intelligence that automated tools miss.
We specialize in deep, hands-on pharmaceutical intelligence for the German-speaking market — combining clinical expertise with meticulous manual research.
Clinical Trial Site Selection
Manual identification and qualification of investigator sites across Germany, Austria, and Switzerland. We go beyond registry data — surfacing active sites, real capacity, and true therapeutic alignment.
HCP Profiling & KOL Mapping
Comprehensive physician profiles built from publications, clinical trial history, congresses, and network relationships. Identify the right Key Opinion Leaders for your indication.
Investigator Intelligence
In-depth investigator profiles including therapeutic expertise, enrollment performance, academic affiliations, and DACH-specific regulatory experience.
AMNOG / G-BA Intelligence
Monitoring and analysis of German AMNOG benefit assessment procedures. We track G-BA dossiers, IQWiG reports, and reimbursement decisions.
Competitive Landscape
Structured intelligence on competitor pipeline activity, clinical positioning, and DACH regulatory status — giving you strategic context.
Patient Recruitment Support
From site feasibility to patient advocacy network mapping in rare disease areas — we bridge clinical operations with on-the-ground DACH intelligence.
Human intelligence
is our edge.
Manual, Qualitative Research
We do not rely on automated database sweeps. Every profile is built by hand, cross-referencing registries, and direct market signals.
DACH-Native Expertise
Deep familiarity with German healthcare structures — G-BA, IQWiG — and the regulatory nuances only practitioners truly understand.
Rare Disease Specialization
Proven track record in rare and ultra-rare indications, including dermatomyositis, IPF, and MASH.
Actionable Intelligence
We deliver structured, analyst-ready outputs — not raw data dumps. Site selection reports ready for your team.
Indications we know deeply.
Our intelligence work spans the entire clinical spectrum, covering all indications from broad primary care to ultra-rare diseases, with particular situational depth in immunology, oncology, and hepatology.